Fast Market Research

Now Available: Global Erectile Dysfunction Drugs Market 2014-2018

Recently published research from TechNavio, "Global Erectile Dysfunction Drugs Market 2014-2018", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 10/02/2014 -- A man's failure to sustain an erection that is adequate enough for sexual activity is known as erectile dysfunction. It also refers to the inconsistency to do so, or the inability to endure it for an extended period. Erectile dysfunction can be due to a number of reasons including aging, high blood pressure, diabetes mellitus, depression, smoking, nerve or spinal cord damage, alcoholism, and low testosterone levels. Treatments for erectile dysfunction include adopting a healthy lifestyle, oral phosphodiesterase type 5 (PDE5) inhibitors, vacuum devices, and surgery. Erectile dysfunction affects the quality of life and leads to stress, anxiety, and self-confidence problems. New research is undergoing in the field of erectile dysfunction to find more enhanced and effective therapies.

View Full Report Details and Table of Contents

TechNavio's analysts forecast the Global Erectile Dysfunction Drugs market to decline at a CAGR of 4.47 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Erectile Dysfunction Drugs market for the period 2014-2018. The Global Erectile Dysfunction Drugs market can be divided into six segments: PDE 5 Inhibitors, Vacuum Constriction Device, Penile Prosthesis, Vascular Reconstructive Surgery, Injection Therapies, and Testosterone Replacement Therapy. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used for the treatment of erectile dysfunction.

TechNavio's report, the Global Erectile Dysfunction Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Erectile Dysfunction Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

- Americas

Key Vendors

- Apricus Biosciences
- Bayer
- Dong-A Socio Holdings
- Eli Lily
- Pfizer
- Vivus

Other Prominent Vendors

- Auxillium Pharmaceuticals
- Cristalia Produtos Quimicos Farmaceuticos
- Futura Medical
- Johnson & Johnson
- Meda Pharmaceuticals
- Pacific Therapeutics
- Seattle Genetics

Market Driver

- Increase in Aging Population
- For a full, detailed list, view our report

Market Challenge

- High Cost
- For a full, detailed list, view our report

Market Trend

- Increased Awareness of Erectile Dysfunction
- For a full, detailed list, view our report

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Apricus Biosciences, Bayer, Dong-A Socio Holdings, Eli Lily, Pfizer, Vivus, Auxillium Pharmaceuticals, Cristalia Produtos Quimicos Farmaceuticos, Futura Medical, Johnson & Johnson, Meda Pharmaceuticals, Pacific Therapeutics, Seattle Genetics

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Erectile Dysfunction Global Clinical Trials Review, H2, 2013
- Erectile Dysfunction - Pipeline Review, H2 2014
- Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2013
- Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014
- Vascular Dysfunction Global Clinical Trials Review, H2, 2013
- Global Infectious Disease Treatment Market 2014-2018
- Global Multiple Sclerosis Drugs Market 2014-2018
- Global Generic Drugs Market 2014-2018
- Global Pain Management Drugs Market 2014-2018
- Global CRAMS Market Outlook to 2018 - India and China Present Bright Prospects